Lumida
/GPAT
⌘K
GPAT

GPAT

GPAT
$11.01USD-0.90%-0.10 today

MARKET CAP

395.7M

P/E (TTM)

FWD P/E

DAY RANGE

$11 – $11

52W RANGE

$10
$12

The case for & against

Bull & Bear analysis

Bearish

GP-Act III Acquisition Corp (GPAT) is a blank check company formed with the intent to effect a merger, share exchange, asset acquisition, or similar business combination. Operating in the SPAC (Special Purpose Acquisition Company) arena, its primary role involves leveraging capital raised in its initial public offering (IPO) to identify and acquire a target operating business. As a part of the broader trend of SPAC popularity, GPAT attempts to provide a more efficient route to public markets for private companies amidst a changing regulatory landscape.

Bull says

  • Market cap ~$391M provides ample acquisition funding
  • Blank check model taps strong SPAC market demand
  • Flexible target scope across tech, healthcare, and renewables
  • Long-term moving averages (MA20–MA200) issue “Buy” signals
  • High earnings yield, solid profitability, and high ROE
  • Low volatility and strong momentum suggest stable upside

Bear says

  • Execution risk in securing a viable merger target
  • Heightened regulatory scrutiny could dampen SPAC appeal
  • P/E of 35.10–35.25 implies speculative valuation
  • Short-term MA5/MA10 “Sell” signals indicate technical weakness
  • No disclosed acquisition targets erode investor confidence
  • Weak sales growth and high short interest signal headwinds